Le Remdesivir (Gilead) efficace sur le MERS-CoV. Attente de résultats sur le 2019-nCov

Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection

Middle East Respiratory Syndrome, caused by the MERS coronavirus (MERS-CoV), continues to cause severe respiratory disease with a high case fatality rate. To date, potential antiviral treatments for

https://www.pnas.org/content/early/2020/02/12/1922083117